Acupuncture modulates development of myopia by reducing NLRP3 inflammasome activation via the dopamine-D1R signaling

Chih-Sheng Chen1,2, Chi-Fong Lin3, Yung-Lan Chou4

  • 1Department of Food Nutrition and Health Biotechnology, Asia University, Taichung.

Abstract

Insights

Acupuncture may inhibit myopia by boosting dopamine levels and activating the dopamine receptor 1 (D1R) pathway, which suppresses inflammation. This research explores acupuncture

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Integrative Medicine

Background:

  • Dopamine acts as a stop signal for eye growth, influencing myopia development.
  • Acupuncture is clinically used for myopia and is known to increase dopamine secretion.

Purpose of the Study:

  • To investigate if acupuncture inhibits myopia progression in Syrian hamsters.
  • To determine if acupuncture-induced dopamine rises suppress inflammasome activation.

Main Methods:

  • Acupuncture applied at LI4 and Taiyang points for 21 days.
  • Assessed dopamine and inflammatory pathway molecules.
  • Used apomorphine (dopamine agonist) and SCH39166 (D1R inhibitor) in RPE cells and hamsters.

Main Results:

  • Acupuncture inhibited myopia development by increasing dopamine and activating the D1R pathway.
  • Dopamine D1R pathway activation suppressed NLRP3 inflammasome activation.
  • Inflammasome activation was inhibited by D1R pathway activation.

Conclusions:

  • Acupuncture inhibits myopia development by suppressing inflammation.
  • This anti-inflammatory effect is mediated by the dopamine-D1R signaling pathway.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
498
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K